Celanese Corporation is a global technology leader in the production of differentiated chemistry solutions, and speciality materials that are used in most major industries and consumer applications. The company, which had net sales of $5.4 billion in 2016, supports the pharmaceutical and life sciences industries by creating custom-polymeric excipients and polymers that are used in combination medical devices.
Drug delivery systems and speciality materials
As a provider of market-ready products, Celanese develops drug delivery systems with high sensitivity, dose accuracy and dosage duration for a wide range of applications. By applying the company's full breadth of expertise in chemistry, technology and global business, Celanese is uniquely positioned to partner with its customers across the supply chain - from developing state-of-the-art drug delivery systems to natural sweeteners that formulate unique taste profiles for patients. The company strives to create value for customers and patients.
Engineering drug delivery devices
Preventing dose non-compliance and controlling bioavailability is becoming the job of the engineered drug delivery technologies that Celanese has been creating for years. The company's VitalDose controlled release ethylene vinyl acetate (EVA) polymer excipients are for a range of implantable, long-acting dosage forms, and Celanese's advanced engineering materials are used in next-generation drug delivery devices, including combination inhalers, dose-monitoring injection pens and other administer methods.
Solutions for materials and biologics
Celanese has a range of materials that are validated and used in developing biologics and commercial products. Of particular note are its VitalDose EVA excipients, which can be blended with therapeutic agents and implanted as delivery vehicles for the controlled release of conventional and biologic active pharmaceutical ingredients. This versatile excipient can be used in a wide range of innovative dosage forms, and is currently used to treat a plethora of conditions.
The regulatory environment: compliance for pharmaceutical excipients
Since it was established over 100 years ago, Celanese has gained a solid track record with regulators globally, and its pharmaceutical excipients are FDA-listed. The footprint of the technology and speciality materials expert stretches from Dallas to Amsterdam and Shanghai, and it is well regarded for assisting with streamlining the development, approval and commercialisation process - no matter the size of the project.
Partnering and development
Customers face a variety of challenges in deciding how their new formulations should be delivered. With Celanese as a development partner, they gain the support of a long-standing company with a track record in advancing breakthrough drug delivery methods - from concept through to commercial reality - to fit the individual needs of global customers.